Title
Category
Credits
Event date
Cost
A Patient's Perspective: Pain After Surgery - (Previously Recorded April 2025 Lunch and Learn)
  • Compass SHARP
  • Patient Harm
  • Substance and Opioid Use Disorder
  • 0.50 AMA PRA Category 1 Credit™
$0.00
This monthly learning event addresses the important issue of postoperative pain management, focusing on the detrimental impact of stigma. Participants will explore the complex nature of postoperative pain, acknowledging the interplay of physical, emotional, and social factors that shape a patient's experience. A key emphasis will be placed on recognizing and mitigating the stigma patients face when discussing or seeking treatment for pain, which often creates obstacles to effective care.
SHARP Six Part Mini-Lecture Series
  • Compass SHARP
  • Patient Harm
  • Substance and Opioid Use Disorder
  • 2.50 AMA PRA Category 1 Credit™
$0.00
This comprehensive six-part lecture series provides a detailed overview of perioperative pain management, encompassing all stages of the surgical journey—from preoperative assessment and planning to long-term post-operative care.  The series will cover the opioid crisis and responsible opioid prescribing, then delve into the development and implementation of effective multimodal analgesia plans, integrating both pharmacological and regional anesthesia techniques.
Colorado Consortium for Prescription Drug Abuse Prevention
  • Colorado Consortium for Prescription Drug Abuse Prevention
  • Substance and Opioid Use Disorder
$0.00
The Colorado Consortium for Prescription Drug Abuse Prevention’s Provider Education Work Group seeks to engage and educate a broad range of health care providers across Colorado. More specifically, the goal of the work group is to increase knowledge around pain management, safe opioid prescribing, and substance use disorder treatment by using a variety of educational tools. On this page, you will find links to numerous training modules developed by the Consortium. The modules last up to an hour, can be completed at your convenience, and are eligible for Continuing Medical Education credits. CoBank has been a generous sponsor for this work. The State of Colorado also provided funding through the Behavioral Health Recovery Act of 2021 (SB21-137).
A Deeper Dive into the CDC Guidelines: Implementation and Practice
  • Colorado Consortium for Prescription Drug Abuse Prevention
  • Substance and Opioid Use Disorder
  • 1.00 AMA PRA Category 1 Credit™
$0.00
This module provides a detailed and practical approach to implementing the CDC Clinical Practice Guidelines Recommendations 1 through 10 in clinical practice with case examples. The remainder of the webinar addresses opioid stewardship and how to universally apply the guidelines at a practice level and at an individual level.   
Opioids: An Objective Look at the Good, the Bad and the Ugly of One of Medicines Most Utilized Drugs
  • Substance and Opioid Use Disorder
  • 0.00 AMA PRA Category 1 Credit™
$0.00
An Objective Look at the Good, the Bad and the Ugly of One of Medicine's Most Utilized Drugs, provides a balanced perspective on opioid therapy.
Alternatives to Opioids (ALTOs) for the Treatment of Pain: The Opportunity to Provide Better, Safe Pain Control
  • Substance and Opioid Use Disorder
$0.00
Alternatives to Opioids (ALTOs) for the Treatment of Pain: The Opportunity to Provide Better, Safe Pain Control, explores a comprehensive approach to pain management beyond opioids. This session will begin by establishing a foundation in pain physiology, enabling participants to effectively identify different pain types. The lecture will then introduce the multimodal pain philosophy, emphasizing a holistic approach to pain management.
Pain is More than We Understand it to be: Understanding Pain Psychology and How to Have Better Conversations at the Bedside-CME Paid Option
  • Substance and Opioid Use Disorder
  • 1.00 AMA PRA Category 1 Credit™
$25.00
Understanding Pain Psychology and How to Have Better Conversations at the Bedside," delves into the complex interplay between pain, psychology, and social factors. This session will clarify the distinctions between nociception, pain, and suffering, emphasizing their unique characteristics within the pain experience. Participants will gain an understanding of how psychological and social factors contribute to chronic pain, exploring the multifaceted nature of persistent pain.
Chronic Pain Management: Best Practices-CME Paid Option
  • Substance and Opioid Use Disorder
  • 0.50 AMA PRA Category 1 Credit™
$25.00
Chronic Pain Management: Best Practices, focuses on the practical aspects of managing chronic pain, particularly with opioid therapy. This session will guide participants in identifying appropriate candidates for chronic opioid therapy initiation and provide strategies for effectively discussing expectations with these patients. The lecture will cover the implementation of appropriate monitoring techniques for chronic opioid therapy, including methods to minimize side effects and adverse outcomes.
Chronic Pain Management: Best Practices
  • Substance and Opioid Use Disorder
  • 0.00 AMA PRA Category 1 Credit™
$0.00
Chronic Pain Management: Best Practices, focuses on the practical aspects of managing chronic pain, particularly with opioid therapy. This session will guide participants in identifying appropriate candidates for chronic opioid therapy initiation and provide strategies for effectively discussing expectations with these patients. The lecture will cover the implementation of appropriate monitoring techniques for chronic opioid therapy, including methods to minimize side effects and adverse outcomes.
Physician Protect Thyself: The Risks of Liberal Opioid Prescribing
  • Substance and Opioid Use Disorder
$0.00
The prescribing of opioids and other controlled substances presents significant legal and practice risks for healthcare providers. Liberal prescribing practices can lead to criminal liability, malpractice claims, medical board sanctions, and program exclusions, putting both patient safety and professional licensure at risk. Additionally, abrupt discontinuation of opioids poses serious concerns, including patient harm, withdrawal complications, and potential legal repercussions.

Pages